about
Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoeaRoles and relevance of mast cells in infection and vaccinationPlant-based solutions for veterinary immunotherapeutics and prophylacticsFunctional testing of an inhalable nanoparticle based influenza vaccine using a human precision cut lung slice techniqueInducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.Mucosal vaccines against respiratory syncytial virusVaccines against poverty.Human cytomegalovirus tropism for mucosal myeloid dendritic cells.Development of stable Vibrio cholerae O1 Hikojima type vaccine strains co-expressing the Inaba and Ogawa lipopolysaccharide antigens.The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigensOral bacillus Calmette-Guérin vaccine against tuberculosis: why not?Natural killer T cell and TLR9 agonists as mucosal adjuvants for sublingual vaccination with clade C HIV-1 envelope protein.Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e.The ocular conjunctiva as a mucosal immunization route: a profile of the immune response to the model antigen tetanus toxoid.Vaginal immunization to elicit primary T-cell activation and dissemination.Antibiotic treatment suppresses rotavirus infection and enhances specific humoral immunity.Microneedle Vaccination Elicits Superior Protection and Antibody Response over Intranasal Vaccination against Swine-Origin Influenza A (H1N1) in MiceReplication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy.Serum and mucosal antibody responses to inactivated polio vaccine after sublingual immunization using a thermoresponsive gel delivery system.Bolstering Components of the Immune Response Compromised by Prior Exposure to Adenovirus: Guided Formulation Development for a Nasal Ebola VaccineCharacterization of the Antigen-Specific CD4(+) T Cell Response Induced by Prime-Boost Strategies with CAF01 and CpG Adjuvants Administered by the Intranasal and Subcutaneous RoutesVACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells.Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Acute effects of rotavirus and malnutrition on intestinal barrier function in neonatal pigletsPulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection.Oral immunization with Escherichia coli expressing a lipidated form of LigA protects hamsters against challenge with Leptospira interrogans serovar Copenhageni.Contribution of Maternal Immunity to Decreased Rotavirus Vaccine Performance in Low- and Middle-Income Countries.The development and role of microbial-host interactions in gut mucosal immune development.Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.Anti-infective activities of lactobacillus strains in the human intestinal microbiota: from probiotics to gastrointestinal anti-infectious biotherapeutic agentsLive attenuated vaccines against pertussis.Development of a new tuberculosis vaccine: is there value in the mucosal approach?Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene.Human milk oligosaccharides inhibit rotavirus infectivity in vitro and in acutely infected piglets.Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles.Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.Nasal and pulmonary vaccine delivery using particulate carriers.Alternative administration routes and delivery technologies for polio vaccines.Antibodies Damage the Resilience of Fimbriae, Causing Them To Be Stiff and TangledCurrent state and challenges in developing oral vaccines.
P2860
Q24201328-1864CD4C-70C7-42B3-ADD5-22BFC2036746Q26777264-09854739-EC2A-407A-9368-5C23DD39BD1CQ27000876-7A340A34-2147-4052-9462-A67284D8E3FFQ28535298-90B0A1CE-E1CC-4E4F-925B-AF4D4B35F725Q33793770-7700F840-802F-45A2-9D16-2F03673A115BQ33837530-D8E30315-7BE2-4DE9-8AFD-84472BB4B082Q34119892-1AE8599E-34E8-45B7-A872-5E077B1D8921Q34422068-CAACF1EA-710D-450E-B613-CE0571E0552AQ34512752-BF59B624-E6F2-475E-AC74-BC9A88222B6CQ34532223-A26BF10D-2B23-4C74-A08E-78AFE2C00705Q34548500-7E4F7ECA-70A6-4803-B0A5-32705747BD4AQ34625185-3C3060FD-82E4-4C24-8D97-1CB158C87A59Q34650849-5597D7AF-6983-4746-9B96-D70A950C7C3BQ34699952-684A2A91-BBC2-4790-A42D-F6569DDCEA33Q35069383-158471D4-7E45-48E2-B64C-5F0C97F1DEA7Q35443349-09756EEE-F485-43A7-9D71-93F702DF82D8Q35667123-7277C454-2E73-4C5F-B1A5-F6D0D3410927Q35784865-C79654B7-3C7C-46BC-936B-6E63ED54F01BQ35886523-53426FAC-F914-4EEC-A5D4-0A7F2FD62732Q35917496-7BEF33E1-25FB-4324-BEF0-DD656F4CFF24Q36002296-B9BB07F1-ECEF-4B63-8A85-30B2A5D1C0BFQ36161076-2C2F338A-DF32-4715-8C6E-C0B7D6BEE0E6Q36970645-73FADA21-6FC0-4137-843A-613BBA07678CQ37102462-719DCDA2-B424-474F-899D-9CFF11EB8A5FQ37156309-DDE17331-6E7A-477C-B5D7-B8196833CF7FQ37546496-F27A6993-7E69-435A-AE3E-5D98725395B1Q37563622-916F1229-5E34-4176-BF30-B7397203724AQ37609650-3698911A-A2A8-4833-B330-04DF6581AE97Q37679436-F564C4BB-7A41-4B38-B525-158F192644F1Q37712802-8D95D90B-DB2B-475A-8F9A-68DED7398B80Q38236200-2EA3404C-9501-4DF1-A90D-B4AF8E586EDCQ38262258-574739B8-35F9-4608-8F69-430ACD1E6B6BQ38315346-D0BEF04A-B4D4-496D-9F4F-1517152D66C5Q38317449-995A5DD1-F404-4CBB-9AC9-B01EA6178844Q38335733-079E1E54-AAD9-4E7C-8EDE-B292A6C5F94EQ38401993-94BAEC3C-4F03-4D41-A694-D874A1ABA562Q38465267-AE1C577D-8B63-4898-A5CD-C003FA841442Q38748979-CBD126C1-B634-42D4-BDFD-A7D3851FDAD7Q39235361-D40A1245-9AE2-435C-BB76-03AF9F8772E4Q39259629-59C10916-F9B3-4FD4-8E6D-EE4CE31AFFF8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Vaccines against mucosal infections.
@en
type
label
Vaccines against mucosal infections.
@en
prefLabel
Vaccines against mucosal infections.
@en
P1476
Vaccines against mucosal infections.
@en
P304
P356
10.1016/J.COI.2012.03.014
P577
2012-05-12T00:00:00Z